Cibc Private Wealth Group, LLC Neurocrine Biosciences Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 59 shares of NBIX stock, worth $8,375. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 1,045
94.35%
Holding current value
$8,375
Previous $142,000
95.77%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
687Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.39 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$790 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$634 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$438 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...